Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-17-000113

Chief Medical Officer and SVP acquired 27,381 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Stromatt Scott C Chief Medical Officer and SVP 2017-02-03 Option exercise +27,381 29,625 D
Derivatives
Stromatt Scott C Chief Medical Officer and SVP 2017-02-03 Option exercise · Restricted Stock Unit −27,381 206,941 D
Loading xslF345X03/stromatt_4.xml…